SCHEMBL24088307

SCHEMBL24088307

c1ccc(N(c2ccccc2)c2ccc3sc4ccc(N(c5ccccc5)c5cc(N(c6ccccc6)c6ccccc6)c6c(c5)sc5ccccc56)cc4c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CYP1A2 P05177 2/20 0.33
MAPT P10636 4/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DUSP3 P51452 2/20 0.32
PTPN7 P35236 1/20 0.32
PTPN12 Q05209 1/20 0.32
PTPN22 Q9Y2R2 1/20 0.32
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25890982 0.99 GPR3 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL21936960 0.99 GPR3 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL21936533 0.96 ALDH1A1 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL24088333 0.96 ALDH1A1 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL21936527 0.96 ALDH1A1 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL24088321 0.96 ALDH1A1 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL21936578 0.96 ALDH1A1 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL21936521 0.96 ALDH1A1 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL22506017 0.96 GPR3 (0.38) GPR3MAOAMAOBCYP1A2MAPT
SCHEMBL21936958 0.94 ALDH1A1 (0.36) GPR3MAOAMAOBCYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380568-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380568-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, VDAC2 GPR3 4843/4885MAOA 1396/4885MAOB 2811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.